Loading...
XSWXCPHN
Market cap494mUSD
Dec 23, Last price  
74.00CHF
1D
1.65%
1Q
19.35%
Jan 2017
85.00%
Name

CPH Chemie und Papier Holding AG

Chart & Performance

D1W1MN
XSWX:CPHN chart
P/E
5.63
P/S
0.71
EPS
13.15
Div Yield, %
6.08%
Shrs. gr., 5y
—
Rev. gr., 5y
3.03%
Revenues
624m
-13.98%
426,196,000462,561,000507,758,000593,523,000570,358,000481,674,000417,396,000520,932,000488,691,000481,850,000492,817,000420,278,000437,546,000473,123,000537,391,000524,657,000445,189,000496,693,000725,351,000623,982,000
Net income
79m
-21.86%
24,530,00044,961,00049,464,00043,379,00030,596,00035,782,000-20,010,000-17,991,0008,061,000-271,480,00010,502,000-33,122,999-7,905,00015,983,00042,293,00048,341,00046,901,000-151,559,000100,953,00078,885,000
CFO
110m
+12.53%
53,989,00084,709,00088,929,00068,881,00082,331,000182,086,00079,445,000-13,808,00040,757,00031,409,00019,819,00023,313,00021,875,00032,189,99964,290,00061,027,00054,958,00015,833,00097,628,000109,862,000
Dividend
Jun 25, 202426 CHF/sh
Earnings
Feb 18, 2025

Profile

CPH Chemie + Papier Holding AG, together with its subsidiaries, engages in developing, manufacturing, and distributing chemicals, printing paper, and pharmaceutical packaging films. The Chemistry division develops, manufactures, and distributes a range of molecular sieves, special zeolites, chromatography gels, and deuterated solvents under the Zeochem brand. The Paper division manufactures newsprint and magazine paper products under the Perlen Papier brand; and recycles domestically recovered paper. The Packaging division provides a range of PVC monofilms and coated PVdC high-barrier films for use in the pharmaceutical industry under the Perlen Packaging brand name. It operates in Switzerland, rest of Europe, the Americas, Asia, and internationally. The company was founded in 1818 and is headquartered in Root, Switzerland.
URL
https://www.cph.ch/
IPO date
Jun 11, 2001
Employees
1,184
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
623,982
-13.98%
725,351
46.04%
496,693
11.57%
Cost of revenue
399,314
600,141
499,616
Unusual Expense (Income)
NOPBT
224,668
125,210
(2,923)
NOPBT Margin
36.01%
17.26%
Operating Taxes
12,974
(886)
2,195
Tax Rate
5.77%
NOPAT
211,694
126,096
(5,118)
Net income
78,885
-21.86%
100,953
-166.61%
(151,559)
-423.15%
Dividends
(27,000)
(7,800)
(10,798)
Dividend yield
5.30%
1.67%
2.95%
Proceeds from repurchase of equity
(588)
10,975
(159)
BB yield
0.12%
-2.35%
0.04%
Debt
Debt current
723
98,851
3,227
Long-term debt
102
106,595
Deferred revenue
95
Other long-term liabilities
30,166
27,385
18,510
Net debt
(116,917)
(69,757)
(16,429)
Cash flow
Cash from operating activities
109,862
97,628
15,833
CAPEX
(34,646)
(33,905)
(24,595)
Cash from investing activities
(17,999)
(29,620)
(19,218)
Cash from financing activities
(125,662)
(18,988)
(17,977)
FCF
225,833
85,226
144,304
Balance
Cash
107,640
143,614
95,116
Long term investments
10,000
25,096
31,135
Excess cash
86,441
132,442
101,416
Stockholders' equity
436,679
399,567
310,494
Invested Capital
380,719
391,498
336,144
ROIC
54.83%
34.66%
ROCE
46.97%
23.64%
EV
Common stock shares outstanding
5,999
6,000
6,000
Price
85.00
8.97%
78.00
27.87%
61.00
-15.98%
Market cap
509,874
8.95%
467,990
27.87%
365,989
-15.97%
EV
392,957
399,590
350,928
EBITDA
243,870
143,839
25,462
EV/EBITDA
1.61
2.78
13.78
Interest
1,389
2,940
2,959
Interest/NOPBT
0.62%
2.35%